SCHEMBL2008079

SCHEMBL2008079

C=CCc1cc(C(C)NS(=O)(=O)c2ccc(F)c(F)c2)ccc1-c1cc(F)ccc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 4/20 0.43
PGR P06401 4/20 0.43
ALDH1A1 P00352 3/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
MEN1 O00255 1/20 0.37
THRB P10828 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
ACHE P22303 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
CETP P11597 1/20 0.36
NPC1 O15118 1/20 0.35
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
MEP1B Q16820 1/20 0.35
ELANE P08246 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2005610 0.81 NR3C1 (0.62) NR3C1PGRALDH1A1LMNAMAPT
SCHEMBL2005613 0.81 NR3C1 (0.62) NR3C1PGRALDH1A1LMNAMAPT
SCHEMBL2005113 0.77 GABRA1 (0.41) NR3C1PGRALDH1A1CETPELANE
SCHEMBL2004275 0.73 NR3C1 (0.51) NR3C1PGRALDH1A1LMNAMAPT
SCHEMBL2004967 0.69 NR3C1 (0.76) NR3C1PGRMAPTMEN1KMT2A
SCHEMBL2006747 0.69 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AELANE
SCHEMBL2006986 0.69 NR3C1 (0.72) NR3C1PGRALDH1A1LMNAMAPT
SCHEMBL4971189 0.66 F7 (0.36) ALDH1A1LMNAMAPTHTTCETP
SCHEMBL2004688 0.66 ALDH1A1 (0.47) NR3C1PGRALDH1A1LMNAMAPT
SCHEMBL21358033 0.65 GABRA1 (0.56) ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960365-B2 Compounds with medicinal effects due to interaction with the glucocorticoid receptor N.V. ORGANON (NL) 2011-06-14 US disclosed
US-20070149577-A1 Compounds with medicinal effects due to interaction with the glucocorticoid receptor N.V. ORGANON (NL) 2007-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149577-A1 Compounds with medicinal effects due to interaction with the glucocorticoid receptor NR3C1, NR3C2, MC2R NR3C1 1/4885PGR 131/4885ALDH1A1 1050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.